<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="4931">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01997502</url>
  </required_header>
  <id_info>
    <org_study_id>494171</org_study_id>
    <nct_id>NCT01997502</nct_id>
  </id_info>
  <brief_title>Accuracy of SpHb Monitoring</brief_title>
  <official_title>Prospective Observational Study Characterizing Noninvasive Hemoglobin (SpHb) Measured With Pulse Co-Oximetry Technology in a Variety of Surgical Cases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Davis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Davis</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      This protocol is a request from Masimo to assist in the collection of data to be used to
      further refine the accuracy of the monitor's algorithm.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The specific aim of this study is to collect data to characterize Masimo's noninvasive
      Rainbow SpHb technology during surgeries.  The purpose is to compare Masimo Rainbow
      technology to arterial blood samples taken during surgery.  Hemoglobin concentrations in the
      arterial blood samples will be measured using standard blood analyzers on site and/or the
      sponsor's laboratory.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Prospective Observational Study Characterizing Noninvasive Hemoglobin (SpHb) Measured with Pulse CO-Oximetry Technology in a Variety of Surgical Cases</measure>
    <time_frame>One year.</time_frame>
    <safety_issue>No</safety_issue>
    <description>Correlation between standard, lab-based, hemoglobin measurement and concurrent SpHgb.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Accuracy of Non-invasive Hemoglobin Measurement.</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients scheduled for elective surgery.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled for elective surgery requiring intra-arterial pressure monitoring.

        Exclusion Criteria:

          -  Age &lt;18 years.  Pregnancy.  Prisoners.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Neal Fleming, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor, Director, Cardiovascular and Thoracic Anesthesiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Neal W Fleming, M.D., Ph.D.</last_name>
    <phone>916-734-5394</phone>
    <email>neal.fleming@ucdmc.ucdavis.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carolyn Murdock</last_name>
    <phone>916-734-5394</phone>
    <email>carolyn.murdock@ucdmc.ucdavis.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UC Davis Health System</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 21, 2013</lastchanged_date>
  <firstreceived_date>November 1, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Davis</investigator_affiliation>
    <investigator_full_name>Neal Fleming, MD, PhD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Hemoglobin</keyword>
  <keyword>Non-invasive</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
